research

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

Authors
Publication date
1 January 2015
Publisher
Digital Commons@Becker
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Digital Commons@Becker

      redirect
      oaioai:digitalcommons.wustl.edu:o...
      Last time updated on 19/11/2016